📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: VNUS

1.1 - Company Overview

VNUS Logo

VNUS

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of products and minimally invasive treatments for venous diseases, including the patented Closure System for patients with symptoms associated with venous reflux; a world leader in the development and marketing of minimally invasive treatments for venous diseases.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to VNUS

Gemphire Therapeutics Logo

Gemphire Therapeutics

HQ: United States Website
  • Description: Provider of Gemcabene, an LDL cholesterol-lowering medication, which it manufactures and markets.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Gemphire Therapeutics company profile →
Kestra Medical Logo

Kestra Medical

HQ: United States Website
  • Description: Provider of wearable medical devices and cloud-based patient data platforms, offering the ASSURE Cardiac Recovery System—a wearable cardioverter defibrillator for detecting and defibrillating ventricular arrhythmias—Kestra CareStation for remote patient progress data and notifications, and the ASSURE Patient App to transmit heart rhythm data and support recovery monitoring.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Kestra Medical company profile →
LimFlow Logo

LimFlow

HQ: France Website
  • Description: Provider of minimally invasive vascular devices for chronic limb-threatening ischemia. The LimFlow System diverts blood around blocked arteries into tibial veins to restore foot perfusion, and includes the LimFlow ARC arterial catheter, V-Ceiver venous catheter, Vector valvulotome, Extension Covered Stents, and Crossing Stents. Approved in CE Mark markets; investigational use only in the U.S.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full LimFlow company profile →
Avinger Logo

Avinger

HQ: United States Website
  • Description: Provider of catheter-based medical devices and intravascular imaging consoles for treating vascular diseases, including peripheral artery disease. Products include Pantheris for atherectomy; Ocelot and TigerEye catheters for crossing chronic total occlusions with real-time imaging; the Lightbox 3 console with onboard OCT; Lumivascular technology combining imaging with therapy; and the Wildcat catheter for PAD.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Avinger company profile →
Capricor Logo

Capricor

HQ: United States Website
  • Description: Provider of cell and exosome-based therapeutics, including CAP-1002, an allogeneic cardiosphere-derived cell therapy in Phase 3 for Duchenne muscular dystrophy; the StealthX exosome platform for designer protein surface expression, cargo loading and targeted delivery to enable precision therapeutics and vaccines; and an exosome-based multivalent SARS-CoV-2 vaccine under development with the NIH.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Capricor company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for VNUS

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to VNUS

2.2 - Growth funds investing in similar companies to VNUS

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for VNUS

4.2 - Public trading comparable groups for VNUS

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to VNUS

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About VNUS

What does VNUS do?

VNUS is a provider of products and minimally invasive treatments for venous diseases, including the patented Closure System for patients with symptoms associated with venous reflux; a world leader in the development and marketing of minimally invasive treatments for venous diseases.

Who are VNUS's competitors?

VNUS's competitors and similar companies include Gemphire Therapeutics, Kestra Medical, LimFlow, Avinger, and Capricor.

Where is VNUS headquartered?

VNUS is headquartered in United States.

How many employees does VNUS have?

VNUS has 1,000 employees 🔒.

When was VNUS founded?

VNUS was founded in 2010 🔒.

What sector and industry vertical is VNUS in?

VNUS is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for VNUS

Who are the top strategic acquirers in VNUS's sector and industry

Top strategic M&A buyers and acquirers in VNUS's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for VNUS?

Top strategic M&A buyers groups and sectors for VNUS include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in VNUS's sector and industry vertical

Which are the top PE firms investing in VNUS's sector and industry vertical?

Top PE firms investing in VNUS's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in VNUS's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in VNUS's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in VNUS's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to VNUS include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in VNUS's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for VNUS?

The key public trading comparables and valuation benchmarks for VNUS include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for VNUS for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for VNUS with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in VNUS's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for VNUS with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in VNUS's' sector and industry vertical?

Access recent funding rounds and capital raises in VNUS's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for VNUS